Page last updated: 2024-09-03

(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Lung Neoplasms

(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bedikian, AY; Del Vecchio, M1
Figlin, RA; Hoffman, DM1

Reviews

1 review(s) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Lung Neoplasms

ArticleYear
Allovectin-7 therapy in metastatic melanoma.
    Expert opinion on biological therapy, 2008, Volume: 8, Issue:6

    Topics: Animals; beta 2-Microglobulin; Cancer Vaccines; Clinical Trials as Topic; DNA, Recombinant; Drug Screening Assays, Antitumor; Genetic Vectors; HLA-B7 Antigen; Humans; Immunotherapy, Active; Injections, Intralesional; Lipids; Lung Neoplasms; Macaca fascicularis; Melanoma; Mice; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Skin Neoplasms; Tumor Escape; Vaccines, DNA

2008

Trials

1 trial(s) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Lung Neoplasms

ArticleYear
Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex.
    World journal of urology, 2000, Volume: 18, Issue:2

    Topics: Aged; Biopsy; Carcinoma, Renal Cell; Gene Transfer Techniques; Humans; Immunotherapy; Interleukin-2; Kidney Neoplasms; Lipids; Liver Neoplasms; Lung Neoplasms; Male; Plasmids; Quaternary Ammonium Compounds; Recombinant Proteins; Transgenes

2000